atomoxetine NDC 16714-757

Product information

Brand name (proprietary)

atomoxetine

Generic name (nonproprietary)

atomoxetine

Active ingredients

Atomoxetine hydrochloride — 25 mg/1

Dosage form

Capsule

Route

Oral

Labeler

Northstar Rx LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 079019

Marketing start

Jun 1, 2018

Listing expires

Dec 31, 2027

Other FDA classes

Norepinephrine Uptake Inhibitors (Mechanism)

Identifiers

Product ID 16714-757_a0f55e56-0899-430c-b25d-475d713f3a93SPL ID a0f55e56-0899-430c-b25d-475d713f3a93SPL set ID 133a4b65-762b-4712-baba-2442546f0379RxCUI 349591, 349592, 349593, 349594, 349595, 608139, 608143UNII 57WVB6I2W0UPC 0316714760018, 0316714755014, 0316714756011, 0316714761015, 0316714757018

Pharmacologic class

Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416714075701 followed by a unit qualifier and the quantity Copy

Package 16714-0757-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 079019

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.